New treatments and blood tests to detect Alzheimers’

A Stanford team have developed a potentially pathbreaking blood test that, according to preliminary studies, is able to identify patients with Alzheimer’s disease – an ailment that has been notoriously difficult to diagnose.

Another group has determined that the prevention of pyro-glutamate A” aggregation is an important mechanism and therapeutic target for treating Alzheimers’.